Thromboelastography in veterinary medicine

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 7, 2010, Pages 747-756

  Wiinberg, Bo ^a   Kristensen, Annemarie T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

canine; equine; feline; Hemostasis; mouse; pig; rabbit; ROTEM; TEG

Indexed keywords

ACETYLSALICYLIC ACID; CARPROFEN; CLOPIDOGREL; DALTEPARIN; DERACOXIB; ENOXAPARIN; HEPARIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE PLASMINOGEN ACTIVATOR;

ANALYTIC METHOD; ANTICOAGULATION; BLOOD COMPONENT; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; HEMOSTASIS; HYPERCOAGULABILITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOSIS; VETERINARY MEDICINE;

ANIMALS; BLOOD COAGULATION DISORDERS; THROMBELASTOGRAPHY;

EID: 78049264005     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1265291     Document Type: Review

References (64)

1. Butenas S, Branda R F., van't Veer C, Cawthern K M., Mann K G. Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost 2001 86 (2) 660-667
2. Hemker H C., van Rijn J L., Rosing J, van Dieijen G, Bevers E M., Zwaal R F. Platelet membrane involvement in blood coagulation. Blood Cells 1983 9 (2) 303-317
3. Hoffman M, Monroe D III.M.. A cell-based model of hemostasis. Thromb Haemost 2001 85 (6) 958-965
4. McVey J H. Tissue factor pathway. Baillieres Best Pract Res Clin Haematol 1999 12 (3) 361-372
5. Rosing J, van Rijn J L., Bevers E M., van Dieijen G, Comfurius P, Zwaal R F. The role of activated human platelets in prothrombin and factor X activation. Blood 1985 65 (2) 319-332
6. Burstein S A., Peng J, Friese P et al. Cytokine-induced alteration of platelet and hemostatic function. Stem Cells 1996 14 (Suppl 1) 154-162
7. Franco R F., de Jonge E, Dekkers P E. et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 2000 96 (2) 554-559
8. Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004 36 (1) 41-49
9. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983 49 (1) 5-7
10. Wiinberg B, Jensen A L., Kjelgaard-Hansen M et al. Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J 2007 174 (1) 62-68
11. Lindblad B, Borgström A, Wakefield T W., Whitehouse W Jr.M., Stanley J C. Haemodynamic and haematologic alterations with protamine reversal of anticoagulation: comparison of standard heparin and a low molecular weight heparin fragment. Eur J Vasc Surg 1987 1 (3) 181-185
12. Logan J C., Callan M B., Drew K et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 2001 218 (9) 1449-1455
13. Palmer K G., King L G., Van Winkle T J. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (19891996). J Am Vet Med Assoc 1998 213 (2) 220-224
14. Ross S J., Smith S A., Lekcharoensuk C. Disseminated intravascular coagulation (DIC) in dogs: 252 cases (19992000). J Vet Intern Med 2002 16 (3) 322
15. Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Diagn Invest 2009 21 (5) 641-648
16. Vilar P, Couto C G., Westendorf N, Iazbik C, Charske J, Marín L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 2008 22 (2) 374-379
17. Wiinberg B, Jensen A L., Rojkjaer R, Johansson P, Kjelgaard-Hansen M, Kristensen A T. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005 34 (4) 389-393
18. Epstein K L., Brainard B M., Lopes M A., Barton M H., Moore J N. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor. J Vet Emerg Crit Care (San Antonio) 2009 19 (1) 96-101
19. Paltrinieri S, Meazza C, Giordano A, Tunesi C. Validation of thromboelastometry in horses. Vet Clin Pathol 2008 37 (3) 277-285
20. Leclere M, Lavoie J P., Dunn M, Bédard C. Evaluation of a modified thrombelastography assay initiated with recombinant human tissue factor in clinically healthy horses. Vet Clin Pathol 2009 38 (4) 462-466
21. Velik-Salchner C, Schnürer C, Fries D et al. Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thromb Res 2006 117 (5) 597-602
22. Horn N A., Hecker K E., Bongers B, Baumert H J., Reyle-Hahn S M., Rossaint R. Coagulation assessment in healthy pigs undergoing single xenon anaesthesia and combinations with isoflurane and sevoflurane. Acta Anaesthesiol Scand 2001 45 (5) 634-638
23. Palsgaard-Van Lue A, Strøm H, Lee M H. et al. Cellular, hemostatic, and inflammatory parameters of the surgical stress response in pigs undergoing partial pericardectomy via open thoracotomy or thoracoscopy. Surg Endosc 2007 21 (5) 785-792
24. Anagnostopoulos P V., Shepard A D., Pipinos I I. et al. Analysis of coagulation changes associated with supraceliac aortic crossclamping using thromboelastography. J Surg Res 2001 98 (1) 52-58
25. King D R., Cohn S M., Feinstein A J., Proctor K G. Systemic coagulation changes caused by pulmonary artery catheters: laboratory findings and clinical correlation. J Trauma 2005 59 (4) 853-857; discussion 857859
26. Tomori T, Hupalo D, Teranishi K et al. Evaluation of coagulation stages of hemorrhaged swine: comparison of thromboelastography and rotational elastometry. Blood Coagul Fibrinolysis 2010 21 (1) 20-27
27. Siller-Matula J M., Plasenzotti R, Spiel A, Quehenberger P, Jilma B. Interspecies differences in coagulation profile. Thromb Haemost 2008 100 (3) 397-404
28. Moalic P, Gruel Y, Foloppe P, Delahousse B, Leclerc M H., Leroy J. Hemostasis development in the lamb fetus and neonate. Am J Vet Res 1989 50 (1) 59-63
29. Nielsen V G., Geary B T., Baird M S. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000 91 (1) 35-39
30. Shibata J, Hasegawa J, Siemens H J. et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 2003 101 (11) 4416-4422
31. Wiinberg B, Jensen A L., Rozanski E et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009 179 (1) 121-129
32. Wiinberg B, Jensen A L., Johansson P I., Rozanski E, Tranholm M, Kristensen A T. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008 22 (2) 357-365
33. Wagg C R., Boysen S R., Bédard C. Thrombelastography in dogs admitted to an intensive care unit. Vet Clin Pathol 2009 38 (4) 453-461
34. Otto C M., Rieser T M., Brooks M B., Russell M W. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000 217 (10) 1500-1504
35. Kristensen A T., Wiinberg B, Jessen L R., Andreasen E, Jensen A L. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008 22 (1) 140-147
36. Johansson P I., Stensballe J, Vindeløv N, Perner A, Espersen K. Hypocoagulability, as evaluated by thrombelastography, at admission to the ICU is associated with increased 30-day mortality. Blood Coagul Fibrinolysis 2010 21 (2) 168-174
37. Sinnott V B., Otto C M. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (20002008). J Vet Emerg Crit Care (San Antonio) 2009 19 (5) 484-488
38. Brooks M B., Randolph J, Warner K, Center S. Evaluation of platelet function screening tests to detect platelet procoagulant deficiency in dogs with Scott syndrome. Vet Clin Pathol 2009 38 (3) 306-315
39. Poller L, Thomson J M., Sear C H., Thomas W. Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma. J Clin Pathol 1971 24 (7) 626-632
40. Callan M B., Aljamali M N., Margaritis P et al. A novel missense mutation responsible for factor VII deficiency in research Beagle colonies. J Thromb Haemost 2006 4 (12) 2616-2622
41. Macieira S, Rivard G E., Champagne J, Lavoie J P., Bédard C. Glanzmann thrombasthenia in an Oldenbourg filly. Vet Clin Pathol 2007 36 (2) 204-208
42. Raina S, Spillert C R., Greenstein S M., Lazaro E J. Effect of surgery on tumor-induced accelerated coagulation in a rat carcinoma. J Surg Res 1985 38 (2) 138-142
43. Haid M, Zuckerman L, Caprini J A., Kurtides S, Vagher P. Thromboelastographic changes in carcinoma: an animal model. J Med 1976 7 (3-4) 189-216
44. Mousa S A., Linhardt R, Francis J L., Amirkhosravi A. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin. Thromb Haemost 2006 96 (6) 816-821
45. Olrik Berthelsen L, Thuri Kristensen A, Wiinberg B, Tranholm M. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model. Thromb Res 2009 124 (4) 490-497
46. Kaspereit F, Doerr B, Dickneite G. The effect of fibrinogen concentrate administration on coagulation abnormalities in a rat sepsis model. Blood Coagul Fibrinolysis 2004 15 (1) 39-43
47. Barklin A, Tønnesen E, Ingerslev J, Sørensen B, Fenger-Eriksen C. Coagulopathy during induced severe intracranial hypertension in a porcine donor model. Anesthesiology 2009 110 (6) 1287-1292
48. Othman M, Powell S, Chirinian Y, Hegadorn C, Hopman W, Lillicrap D. Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise. Haemophilia 2009 15 (5) 1126-1134
49. Margaritis P, Roy E, Aljamali M N. et al. Successful treatment of canine hemophilia by continuous expression of canine FVIIa. Blood 2009 113 (16) 3682-3689
50. Ao H, Moon J K., Tashiro M, Terasaki H. Delayed platelet dysfunction in prolonged induced canine hypothermia. Resuscitation 2001 51 (1) 83-90
51. Kheirabadi B S., Crissey J M., Deguzman R, Holcomb J B. In vivo bleeding time and in vitro thrombelastography measurements are better indicators of dilutional hypothermic coagulopathy than prothrombin time. J Trauma 2007 62 (6) 1352-1359; discussion 13591361
52. Alwood A J., Downend A B., Brooks M B. et al. Anticoagulant effects of low-molecular-weight heparins in healthy cats. J Vet Intern Med 2007 21 (3) 378-387
53. Jessen L R., Wiinberg B, Jensen A L. et al. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol 2008 37 (4) 363-372
54. Vernese N A., Spillert C R., Franco C D., Lazaro E J. Thromboelastographic evaluation of mini-dose heparin in minor surgical procedures. Am Surg 1986 52 (2) 112-113
55. Nielsen V G. The detection of changes in heparin activity in the rabbit: a comparison of anti-Xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time. Anesth Analg 2002 95 (6) 1503-1506
56. Brainard B M., Meredith C P., Callan M B. et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007 68 (3) 251-257
57. Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Blood Coagul Fibrinolysis 2008 19 (6) 557-567
58. Sumi H, Sasaki K, Toki N, Robbins K C. Oral administration of urokinase. Thromb Res 1980 20 (56) 711-714
59. Summaria L, Sandesara J, Yang G, Vagher J P., Caprini J A. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses. Thromb Haemost 1986 56 (1) 71-79
60. Flight S M., Masci P P., Lavin M F., Gaffney P J. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator. Blood Coagul Fibrinolysis 2006 17 (5) 417-420
61. Tranholm M, Rojkjaer R, Pyke C et al. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits. Thromb Res 2003 109 (4) 217-223
62. Jankun J, Selman S H., Keck R W., ysiak-Szydowska W, Skrzypczak-Jankun E. Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model. BJU Int 2010 105 (10) 1469-1476
63. Henry M, Davidson L, Cohen Z, McDonagh P F., Nolan P E., Ritter L S. Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice. Diabetes Res Clin Pract 2009 84 (1) 11-18
64. White N J., Martin E J., Brophy D F., Ward K R. Coagulopathy and traumatic shock: characterizing hemostatic function during the critical period prior to fluid resuscitation. Resuscitation 2010 81 (1) 111-116